they are not recommendations for combined use.
Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development
The peptide influences both endothelial nitric oxide synthase (eNOS), which produces the beneficial, vasodilating form of nitric oxide, and inducible nitric oxide synthase (iNOS), which can produce excessive amounts that contribute to inflammation and tissue damage
Clinical trials have shown their efficacy and safety over several years, yet the possibility of long-term adverse effects remains a research focus
The free peptide chelates a Cu ion with high affinity, generating a deep cobalt-blue complex that is the workhorse molecule of modern copper-peptide research